Home
Conditions
DLBCL - Diffuse Large B Cell Lymphoma

Clinical trial condition

DLBCL - Diffuse Large B Cell Lymphoma

Explore clinical trials studying DLBCL - Diffuse Large B Cell Lymphoma. Study availability and eligibility vary by location and protocol.

47 public trials 26 recruiting studies

Refine in advanced search Browse all conditions

DLBCL - Diffuse Large B Cell Lymphoma trial results

Recruiting

Real-World Study of DLBCL With Different Genetic Subtypes

NCT06026488

Conditions: DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +9 more
Locations: Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Comparison of Point-of-care Produced CAR T-cell with Commercial CAR T-cells in Patients with R/R LBCL

NCT05641428

Conditions: DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +6 more
Locations: NL-Amsterdam-AMC Amsterdam, Netherlands

NL-Groningen-UMCG Groningen, Netherlands

NL-Leiden-LUMC Leiden, Netherlands

NL-Maastricht-MUMC Maastricht, Netherlands

View Trial Details

Recruiting

Milaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study

NCT06534762

Conditions: Breast Diseases, Breast Neoplasms, Carcinoma, +45 more
Locations: Zhejiang Provincial People's Hospital Hangzhou, Zhejiang, China

View Trial Details

Recruiting

Molecular Mechanisms in Malignant Lymphoma- Predict (MMML Predict)

NCT06526065

Conditions: DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +5 more
Locations: Universitätsmedizin Göttingen Göttingen, Lower Saxony, Germany

View Trial Details

Recruiting

Epcoritamab (Epcor)-Containing Combination Salvage Therapy Followed by ASCT & Epcor Consolidation in Patients With Relapsed LBCL

NCT06287398

Conditions: DLBCL - Diffuse Large B Cell Lymphoma, DLBCL, Nos Genetic Subtypes, Dendritic Cell Sarcoma, Interdigitating, +21 more
Locations: Australasian Leukemia and Lymphoma Group Melbourne, Victoria, Australia

View Trial Details

Recruiting

Study to Evaluate the Effectiveness of Tafasitamab in Combination With Lenalidomide Followed by Tafasitamab Monotherapy in Relapsed or Refractory Diffuse Large B-cell Lymphoma Non-transplant Eligible Patients in Italy (PRO-MIND)

NCT06299553

Conditions: DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +5 more
Locations: Incyte Biosciences Italy S.r.l Milan, Italy

View Trial Details

Not yet recruiting

Pirtobrutinib Plus Methotrexate-Based Chemoimmunotherapy for Systemic DLBCL With CNS Involvement

NCT07812493

Conditions: CNS Involvement of Systemic Lymphoma, DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, +8 more
Locations: Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China

View Trial Details

Not yet recruiting

Pirtobrutinib+Sonrotoclax（PS) Regimen in the Treatment of B-Cell Lymphoma

NCT07744750

Conditions: CLL / SLL, DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, +8 more
Locations: Jiangsu Province Hospital The First Affiliated Hospital with Nanjing Medical University Nanjing, Jiangsu, China

View Trial Details

Not yet recruiting

Pirtobrutinib + R-CHOP for Untreated Non-GCB DLBCL

NCT07744737

Conditions: DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +7 more
Locations: Jiangsu Province Hospital The First Affiliated Hospital with Nanjing Medical University Nanjing, Jiangsu, China

View Trial Details

Not yet recruiting

Pirtobrutinib+Pola-R-CHP for Newly Diagnosed Non-GCB DLBCL

NCT07744724

Conditions: DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +6 more
Locations: Jiangsu Province Hospital The First Affiliated Hospital with Nanjing Medical University Nanjing, Jiangsu, China

View Trial Details

DLBCL - Diffuse Large B Cell Lymphoma

DLBCL - Diffuse Large B Cell Lymphoma trial results

Related conditions